UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Off-label use of aducanumab for cerebral amyloid angiopathy

Greenberg, SM; Cordonnier, C; Schneider, JA; Smith, EE; van Buchem, MA; van Veluw, SJ; Verbeek, MM; ... Werring, DJ; + view all (2021) Off-label use of aducanumab for cerebral amyloid angiopathy. The Lancet Neurology , 20 (8) pp. 596-597. 10.1016/S1474-4422(21)00213-1. Green open access

[thumbnail of Werring_Aducanumab correspondence draft 6.18.21_clean_DJW_for UCL (2).pdf]
Preview
Text
Werring_Aducanumab correspondence draft 6.18.21_clean_DJW_for UCL (2).pdf - Accepted Version

Download (164kB) | Preview
Type: Article
Title: Off-label use of aducanumab for cerebral amyloid angiopathy
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/S1474-4422(21)00213-1
Publisher version: https://doi.org/10.1016/S1474-4422(21)00213-1
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation
URI: https://discovery.ucl.ac.uk/id/eprint/10131607
Downloads since deposit
94Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item